Ashland Inc. with ticker code (ASH) now have 9 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the high target price and low target price is between $116.00 and $92.00 and has a mean share price target at $103.11. (at the time of writing). Now with the previous closing price of $83.32 and the analysts are correct then there would likely be a percentage uptick in value of 23.8%. The 50 day moving average now sits at $94.15 and the 200 day MA is $90.31. The total market capitalization for the company now stands at 4.05B. The current share price for the company is: $82.85 USD
The potential market cap would be $5,006,654,899 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 24.23, revenue per share of $41.54 and a 1.21% return on assets.
Ashland Inc. is a global additives and specialty ingredients company. It serves customers in a range of consumer and industrial markets, including architectural coatings, automotive, construction, energy, food and beverage, nutraceuticals, personal care and pharmaceuticals. Its segments include life sciences, personal care, specialty additives, and intermediates. The life sciences segment includes pharmaceuticals, nutraceuticals and nutrition, and diagnostic films and agricultural chemicals. The personal care segment skin and sun care, hair care, oral care, home care, and others. The specialty additives segment includes coatings, construction, and energy. The intermediates segment produces and supplies butanediol (BDO), Tetrahydrofuran (THF), n-methyl-pyrrolidone (NMP) and gamma-butyrolactone (GBL, BLO) in addition to other downstream products. Its products include acrylates, aquaflow, biofunctionals, cellulosics, cyclodextrins, encapsulates, emollient esters, emulsifiers, and others.
